Maven Securities LTD Buys New Shares in Alignment Healthcare, Inc. $ALHC

Maven Securities LTD bought a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 50,000 shares of the company’s stock, valued at approximately $872,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Teacher Retirement System of Texas increased its stake in shares of Alignment Healthcare by 85.8% during the 3rd quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company’s stock valued at $1,794,000 after acquiring an additional 47,472 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in shares of Alignment Healthcare in the third quarter worth approximately $3,499,000. Inspire Investing LLC acquired a new stake in shares of Alignment Healthcare in the third quarter worth approximately $1,129,000. Cinctive Capital Management LP purchased a new stake in Alignment Healthcare in the third quarter valued at approximately $3,814,000. Finally, Ameritas Investment Partners Inc. grew its holdings in Alignment Healthcare by 32.9% in the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock valued at $182,000 after purchasing an additional 3,225 shares during the period. 86.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. JPMorgan Chase & Co. increased their price target on shares of Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Robert W. Baird set a $28.00 price objective on shares of Alignment Healthcare in a research note on Friday, January 30th. UBS Group upped their price objective on Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, January 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. Finally, TD Cowen lifted their target price on Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Alignment Healthcare has an average rating of “Moderate Buy” and an average price target of $24.56.

Alignment Healthcare Trading Up 2.3%

Shares of ALHC stock opened at $17.92 on Wednesday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.80. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The firm’s 50 day moving average price is $20.62 and its two-hundred day moving average price is $18.79. The stock has a market cap of $3.66 billion, a price-to-earnings ratio of -1,790.21, a price-to-earnings-growth ratio of 2.56 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.10. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The company had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. During the same quarter in the prior year, the business earned ($0.16) earnings per share. The business’s quarterly revenue was up 44.4% compared to the same quarter last year. On average, analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Andreas P. Wagner sold 21,118 shares of the stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $18.62, for a total value of $393,217.16. Following the completion of the sale, the insider directly owned 148,687 shares in the company, valued at approximately $2,768,551.94. This represents a 12.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO John E. Kao sold 48,899 shares of the firm’s stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $17.45, for a total value of $853,287.55. Following the completion of the transaction, the chief executive officer directly owned 1,519,480 shares in the company, valued at $26,514,926. This trade represents a 3.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 2,096,821 shares of company stock valued at $40,774,893 in the last quarter. Company insiders own 6.60% of the company’s stock.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.